The FDA is in the final states of including language warning about suicidal behavior on labels of 11 epilepsy drugs. Sales of the affected drugs, widely used for nonepilepsy problems such as chronic pain, topped $8 billion last year.
From various sources, including the WSJ Blog.
The drugs include:
* Carbatrol, Equetro, Tegretol, Tegretol XR,
* Felbatol,
* Neurontin,
* Lyrica,
* Gabitril,
* Topamax, and
* Depakote
